Forum Topic News
  • Conversation: Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals

    • November 13, 2018 11:31 AM GMT
    • Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals

      Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB. Enable Injections currently has partnerships with five companies to deliver products that shift treatment to the home with easy, convenient self-administration of new large-volume drugs.
      Read more: https://prn.to/2B3gYr6

Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč